Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer

Hansson, J., Bjartell, A. S., Gadaleanu, V., Dizeyi, N., & Abrahamsson, P.-A. (2002) · The Prostate · doi:10.1002/pros.10121 · Cited by 65

Peroxisome proliferator-activated receptor-α regulates postischemic liver injury

Okaya, T., & Lentsch, A. B. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00191.2003 · Cited by 65

Pancreatic β-Cell Lipotoxicity Induced by Overexpression of Hormone-Sensitive Lipase

Winzell, M. S., Svensson, H. P., Enerbäck, S., Ravnskjær, K., Mandrup, S., Esser, V., Arner, P., Alves‐Guerra, M., Miroux, B., Sundler, F., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2057 · Cited by 65

Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists

Hase, T., Yoshimura, R., Mitsuhashi, M., Segawa, Y., Kawahito, Y., Wada, S., Nakatani, T., & Sano, H. (2002) · Urology · doi:10.1016/s0090-4295(02)01747-8 · Cited by 65

PPARs and the orchestration of metabolic fuel selection

Sugden, M. C., Zariwala, M. G., & Holness, M. J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.014 · Cited by 64

Reassessment of Pioglitazone for Alzheimer’s Disease

Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 71

PPAR‐γ expression modulates insulin sensitivity in C2C12 skeletal muscle cells

Verma, N. K., Singh, J., & Dey, C. S. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706002 · Cited by 65

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis.

Giaginis, C., Giagini, A., & Theocharis, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.005 · Cited by 62

Impaired expression of NADH dehydrogenase subunit 1 and PPARγ coactivator-1 in skeletal muscle of ZDF rats

Jové, M., Salla, J., Planavila, A., Cabrero, À., Michalik, L., Wahli, W., Laguna, J. C., & Vázquez‐Carrera, M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300208-jlr200 · Cited by 64

Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways

Berge, K., Tronstad, K. J., Flindt, E. N., Rasmussen, T. H., Madsen, L., Kristiansen, K., & Berge, R. K. (2001) · Carcinogenesis · doi:10.1093/carcin/22.11.1747 · Cited by 64

Bergamot (Citrus bergamia Risso) Flavonoids and Their Potential Benefits in Human Hyperlipidemia and Atherosclerosis: an Overview

Cappello, A. R., Dolce, V., Iacopetta, D., Martello, M., Fiorillo, M., Curcio, R., Muto, L., & Dhanya, D. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150709110222 · Cited by 64

Tissue-Selective, Bidirectional Regulation of PEX11α and Perilipin Genes through a Common Peroxisome Proliferator Response Element

Shimizu, M., Takeshita, A., Tsukamoto, T., Gonzalez, F. J., & Osumi, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1313-1323.2004 · Cited by 63

Peroxisome proliferator‐activated receptor‐alpha is required for the neurotrophic effect of oleic acid in neurons

Bento‐Abreu, A., Tabernero, A., & Medina, J. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04807.x · Cited by 63

Expression of Peroxisome Proliferator-Activated Receptor α Messenger Ribonucleic Acid and Protein in Human and Rat Testis

Schultz, R., Yan, W., Toppari, J., Völkl, A., Gustafsson, J.-Α., & Pelto‐Huikko, M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6858 · Cited by 63

Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome

Vacca, M., Degirolamo, C., Mariani‐Costantini, R., Palasciano, G., & Moschetta, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.137 · Cited by 66

Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells

Löhrke, B., Viergutz, T., Shahi, S. K., Pöhland, R., Wollenhaupt, K., Goldammer, T., Walzel, H., & KANITZ, W. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590429 · Cited by 63

Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production

Colin, S., Briand, O., Touche, V., Wouters, K., Baron, M., Pattou, F. N., Hanf, R., Tailleux, A., Chinetti, G., Staels, B., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs227 · Cited by 68

Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD

Klepsch, V., Moschen, A. R., Tilg, H., Baier, G., & Hermann‐Kleiter, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01070 · Cited by 63

Relationship between PPARα activation and NO on proximal tubular Na+ transport in the rat

Newaz, M., Ranganna, K., & Oyekan, A. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-1 · Cited by 64

Opposite regulation of PPAR-α and -γ gene expression by both their ligands and retinoic acid in brown adipocytes

Valmaseda, A., Carmona, M. C., Barberà, M. J., Viñas, O., Mampel, T., Iglesias, R., Villarroya, F., & Giralt, M. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00081-7 · Cited by 63

Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18

Liu, H., Zang, C., Fenner, M. H., Liu, D., Possinger, K., Koeffler, H. P., & Elstner, E. (2006) · Blood · doi:10.1182/blood-2005-05-2103 · Cited by 63

Activation of PPARδ up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic β-cells

Wan, J., Jiang, L., Lü, Q., Ke, L., Li, X., & Tong, N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.127 · Cited by 61

The Nuclear Hormone Receptor Peroxisome Proliferator-Activated Receptor β/δ Potentiates Cell Chemotactism, Polarization, and Migration

Tan, N. S., Icre, G., Montagner, A., ten Heggeler-Bordier, B., Wahli, W., & Michalik, L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00436-07 · Cited by 65

Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0219-5 · Cited by 62

Increased Reactive Oxygen Species Production Down-regulates Peroxisome Proliferator-activated α Pathway in C2C12 Skeletal Muscle Cells

Cabrero, À., Alegret, M., Sánchez, R. M., Adzet, T., Laguna, J. C., & Vázquez‐Carrera, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110321200 · Cited by 62

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall

Chinetti, G., Fruchart, J., & Staels, B. (2001) · Zeitschrift für Kardiologie · doi:10.1007/s003920170034 · Cited by 61

Pioglitazone Inhibits Growth of Carcinoid Cells and Promotes TRAIL-Induced Apoptosis by Induction of p21waf1/cip1

Göke, R., Göke, A., Göke, B., El‐Deiry, W. S., & Chen, Y. (2001) · Digestion · doi:10.1159/000048843 · Cited by 62

Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: Role of mangiferin

Girón, M. D., Sevillano, N., Salto, R., Haidour, A., Manzano, M., Jiménez, M. L., Rueda, R., & López-Pedrosa, J. M. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.018 · Cited by 82

Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesity

Liu, T., Wang, J., Tong, Y., Wu, L., Xie, Y., He, P., Lin, S., & Hu, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04840-x · Cited by 65

Identification of miR-106b-93 as a negative regulator of brown adipocyte differentiation

Wu, Y., Zuo, J., Zhang, Y., Xie, Y., Hu, F., Chen, L., Liu, B., & Liu, F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.016 · Cited by 61

Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis

Peters, J. M., Foreman, J. E., & Gonzalez, F. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9320-1 · Cited by 64

Mulberry extract inhibits oleic acid‐induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance

Ou, T., Hsu, M., Chan, K., Huang, C., Ho, H.-H., & Wang, C. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4489 · Cited by 61

The many facets of PPARγ: novel insights for the skeleton

Kawai, M., Sousa, K. M., MacDougald, O. A., & Rosen, C. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00157.2010 · Cited by 62

Multiple Sclerosis is Not a Disease of the Immune System

Corthals, A. (2011) · The Quarterly Review of Biology · doi:10.1086/662453 · Cited by 61

Unique Ability of Troglitazone to Up-Regulate Peroxisome Proliferator-Activated Receptor-γ Expression in Hepatocytes

Davies, G. F., McFie, P. J., Khandelwal, R. L., & Roesler, W. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.72 · Cited by 61

Thiazolidinedione Induces Apoptosis and Monocytic Differentiation in the Promyelocytic Leukemia Cell Line HL60

Hirase, N., Yanase, T., Mu, Y.-M., Muta, K., Umemura, T., Takayanagi, R., & Nawata, H. (1999) · Oncology · doi:10.1159/000055271 · Cited by 61

Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor y

Tontonoz, P., & Nagy, L. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00002 · Cited by 61

Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease

Hunter, R. L., & Bing, G. (2007) · Current Neuropharmacology · doi:10.2174/157015907780077123 · Cited by 61

Rosiglitazone Aggravates Nonalcoholic Fatty Pancreatic Disease in C57BL/6 Mice Fed High-Fat and High-Sucrose Diet

Fernandes‐Santos, C., Carneiro, R. E., Mendonça, L. D. S., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181987d9d · Cited by 60

Oxidized Low Density Lipoprotein Activates Peroxisome Proliferator-activated Receptor-α (PPARα) and PPARγ through MAPK-dependent COX-2 Expression in Macrophages

Taketa, K., Matsumura, T., Yano, M., Ishii, N., Senokuchi, T., Motoshima, H., Murata, Y., Kim‐Mitsuyama, S., Kawada, T., Itabe, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m703318200 · Cited by 60

Genomic Profiling in Nuclear Receptor-Mediated Toxicity

Woods, C. G., Heuvel, J. P. V., & Rusyn, I. (2007) · Toxicologic Pathology · doi:10.1080/01926230701311351 · Cited by 60

Caloric Restriction Is More Efficient than Physical Exercise to Protect from Cisplatin Nephrotoxicity via PPAR-Alpha Activation

Estrela, G. R., Wasinski, F., Batista, R. O., Hiyane, M. I., Felizardo, R. J. F., da Cunha, F. F., de Almeida, D. C., Malheiros, D. M. A. C., Câmara, N. O. S., Barros, C. C., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00116 · Cited by 73

Insights into the Role of PPARβ/δ in NAFLD

Chen, J., Montagner, A., Tan, N. S., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071893 · Cited by 61

The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease

Yang, Z., Danzeng, A., Liu, Q., Zeng, C., Xu, L., Mo, J., Ciren, P., Wang, X., Wang, C., Zhang, B., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.87305 · Cited by 61

Exercise and Regulation of Lipid Metabolism

Noland, R. C. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.06.017 · Cited by 63

The Role of Peroxisome Proliferator‐Activated Receptors in the Development and Physiology of Gametes and Preimplantation Embryos

Huang, J.-C. (2008) · PPAR Research · doi:10.1155/2008/732303 · Cited by 59

Aspirin (ASA) regulates 5‐lipoxygenase activity and peroxisome proliferator‐activated receptor α‐mediated CINC‐1 release in rat liver cells: novel actions of lipoxin A 4 (LXA 4 ) and ASA‐triggered 15‐epi‐LXA 4

Planagumà, A., Titos, E., López‐Parra, M., Gaya, J., Pueyo, G., Arroyo, V., & Clària, J. (2002) · The FASEB Journal · doi:10.1096/fj.02-0224fje · Cited by 60

Further Characterization of the Time-Dependent Vascular Effects of Δ9-Tetrahydrocannabinol

O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095828 · Cited by 60

PPARα-dependent cholesterol/testosterone disruption in Leydig cells mediates 2,4-dichlorophenoxyacetic acid-induced testicular toxicity in mice

Harada, Y., Tanaka, N., Ichikawa, M., Kamijo, Y., Sugiyama, E., Gonzalez, F. J., & Aoyama, T. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1669-z · Cited by 59

Effect of Topical PPARβ/δ and PPARγ Agonists on Plaque Psoriasis

Kuenzli, S., & Saurat, J. ‐. (2003) · Dermatology · doi:10.1159/000068897 · Cited by 60

Peroxisome Proliferator-Activated Receptor γ-Mediated NF-κB Activation and Apoptosis in Pre-B Cells

Schlezinger, J. J., Jensen, B. A., Mann, K. K., Ryu, H., & Sherr, D. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6831 · Cited by 58

Peroxisome-proliferator-activated receptor δ mediates the effects of long-chain fatty acids on post-confluent cell proliferation

Jehl-Piétri, C., Bastie, C. C., Gillot, I., Luquet, S. H., & Grimaldi, P. A. (2000) · Biochemical Journal · doi:10.1042/bj3500093 · Cited by 59

Peroxisome proliferator-activated receptors: Lipid binding proteins controling gene expression

van Bilsen, M., van der Vusse, G., Gilde, A. J., Lindhout, M., & van der Lee, K. V. D. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020553428294 · Cited by 79

Mechanisms and clinical effects of thiazolidinediones

Grossman, S. L., & Lessem, J. N. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.8.1025 · Cited by 58

Differential expression of peroxisome proliferator-activated receptors alpha and gamma gene in various chicken tissues

Meng, H., Li, H., Zhao, J. G., & Gu, Z. (2004) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2004.05.003 · Cited by 58

Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041212 · Cited by 59

Cytokines in non-genotoxic hepatocarcinogenesis

Roberts, R. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1397 · Cited by 58

The Role of Peroxisome Proliferator Activated Receptor α in Peroxisome Proliferation, Physiological Homeostasis, and Chemical Carcinogenesis

Gonzalez, F. J. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-2670-1_9 · Cited by 58

Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities

Gao, Z., & Chen, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.805281 · Cited by 60

Nuclear Receptors and Endocrine Disruptors in Fetal and Neonatal Testes: A Gapped Landscape

Rouiller, V., Guerquin, M.-J., N’Tumba-Byn, T., Muczynski, V., Moison, D., Tourpin, S., Messiaen, S., Habert, R., & Livera, G. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00058 · Cited by 57

JTP‐426467 acts as a selective antagonist for peroxisome proliferator‐activated receptor γ in vitro and in vivo

Nishiu, J., Ito, M., Ishida, Y., Kakutani, M., Shibata, T., Matsushita, M., & Shindo, M. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00536.x · Cited by 56

Drug-induced Liver Steatosis and Phospholipidosis: Cell-Based Assays for Early Screening of Drug Candidates

Donato, M. T., & Gómez-Lechón, M. J. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850001 · Cited by 59

Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs

Yamada, H., Oshiro, E., Kikuchi, S., Hakozaki, M., Takahashi, H., & Kimura, K. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047514 · Cited by 58

The peroxisome proliferator-activated receptor α Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men

Paradis, A.-M., Fontaine‐Bisson, B., Bossé, Y., Robitaille, J., Lemieux, S., Jacques, H., Lamarche, B., Tchernof, A., Couture, P., & Vohl, M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.523 · Cited by 57

PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility

Minge, C., Robker, R., & Norman, R. (2008) · PPAR Research · doi:10.1155/2008/243791 · Cited by 55

Role of the Peroxisome Proliferator‐Activated Receptors, Adenosine Monophosphate‐Activated Kinase, and Adiponectin in the Ovary

Dupont, J., Chabrolle, C., Ramé, C., Tosca, L., & Coyral-Castel, S. (2007) · PPAR Research · doi:10.1155/2008/176275 · Cited by 61

Requirement of PPARα in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation

Lee, S. S. T., Chan, W. Y., Lo, C. K.-C., Wan, D. C., Tsang, D., & Cheung, W. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400078-jlr200 · Cited by 58

PPARγ: observations in the hematopoietic system☆

Greene, M. E., Pitts, J., McCarville, M. B., Wang, X.-S., Newport, J. A., Edelstein, C. L., Lee, F., Ghosh, S., & Chu, S. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00075-7 · Cited by 59

Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport

Fürnsinn, C., Willson, T. M., & Brunmair, B. (2006) · Diabetologia · doi:10.1007/s00125-006-0492-0 · Cited by 56

Repression of TNF-α-Induced E-Selectin Expression by PPAR Activators: Involvement of Transcriptional Repressor LRF-1/ATF3

Nawa, T., Nawa, M., Cai, Y., Zhang, C., UCHIMURA, I., Narumi, S., Numano, F., & Kitajima, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3332 · Cited by 57

Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro

Routh, R. E., Johnson, J. H., & McCarthy, K. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00277.x · Cited by 55

The Role of Nuclear Hormone Receptors in Cannabinoid Function

Pistis, M., & O’Sullivan, S. E. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.008 · Cited by 59

Dysregulation of Leukocyte Trafficking in Type 2 Diabetes: Mechanisms and Potential Therapeutic Avenues

Pezhman, L., Tahrani, A. A., & Chimen, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.624184 · Cited by 61

Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop

Colasante, C., Chen, J., Ahlemeyer, B., & Baumgart‐Vogt, E. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0497 · Cited by 59

Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells

Ninomiya, I., Yamazaki, K., Oyama, K., Hayashi, H., Tajima, H., Kitagawa, H., Fushida, S., Fujimura, T., & Ohta, T. (2014) · Oncology Letters · doi:10.3892/ol.2014.2553 · Cited by 56

The identification of peroxisome proliferator‐activated receptor alpha‐independent effects of oleoylethanolamide on intestinal transit in mice

Cluny, N. L., Keenan, C. M., Lutz, B., Piomelli, D., & Sharkey, K. A. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01248.x · Cited by 56

Transcriptional Modulation of the Immune Response by Peroxisome Proliferator-Activated Receptor-α Agonists in Autoimmune Disease

Gocke, A. R., Hussain, R. Z., Yang, Y., Peng, H., Weiner, J., Ben, L.-H., Drew, P. D., Stüve, O., Lovett‐Racke, A. E., & Racke, M. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713927 · Cited by 54

The endocannabinoid system in cardiovascular function: novel insights and clinical implications

Sierra, S., Luquin, N., & Navarro‐Otano, J. (2017) · Clinical Autonomic Research · doi:10.1007/s10286-017-0488-5 · Cited by 56

PPAR‐γ in the Cardiovascular System

Duan, S. Z., Ivashchenko, C. Y., Usher, M. G., & Mortensen, R. M. (2007) · PPAR Research · doi:10.1155/2008/745804 · Cited by 56

Expression profiling of Peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray

Higashiyama, H., Billin, A. N., Okamoto, Y., Kinoshita, M., & Asano, S. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-007-0279-5 · Cited by 59

Peroxisome proliferator-activated receptor (PPAR)-γ expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-γ activator troglitazone

Benson, S. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00148-x · Cited by 56

Expression of peroxisome proliferator activated receptors (PPARs) in human hair follicles and PPAR alpha involvement in hair growth

Billoni, N., Buan, B., Gautier, B., Collin, C., Gaillard, O., Mahé, Y. F., & Bernard, B. A. (2000) · Acta Dermato Venereologica · doi:10.1080/000155500459240 · Cited by 56

The Functions of PPARs in Aging and Longevity

Erol, A. (2007) · PPAR Research · doi:10.1155/2007/39654 · Cited by 54

Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain

Pellet, J., Haefliger, J., Staple, J. K., Widmann, C., Welker, E., Hirling, H., Bonny, C., Nicod, P., Catsicas, S., Waeber, G., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00945.x · Cited by 55

SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ

Khan, D., Ara, T., Ravi, V., Rajagopal, R., Tandon, H., Parvathy, J., Gonzalez, E. A., Asirvatham‐Jeyaraj, N., Krishna, S., Mishra, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109190 · Cited by 58

Road to exercise mimetics: targeting nuclear receptors in skeletal muscle

Fan, W., Atkins, A. R., Yu, R. T., Downes, M., & Evans, R. M. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0258 · Cited by 57

Oxidative Stress and Heme Oxygenase‐1 Regulated Human Mesenchymal Stem Cells Differentiation

Vanella, L., Sanford, C., Kim, D. H., Abraham, N. G., & Ebraheim, N. A. (2012) · International Journal of Hypertension · doi:10.1155/2012/890671 · Cited by 55

Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats

Azari, E. K., Leitner, C., Jaggi, T., Langhans, W., & Mansouri, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074869 · Cited by 55

Activation of PPAR α and PPAR β/δ regulates Sertoli cell metabolism

Regueira, M., Riera, M. F., Galardo, M. N., Pellizzari, E. H., Cigorraga, S. B., & Meroni, S. B. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.006 · Cited by 57

Role of retinoic acid receptor (RAR) signaling in post-natal male germ cell differentiation

Mark, M. P., Teletin, M., Vernet, N., & Ghyselinck, N. B. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.019 · Cited by 55

Sports genomics: Current state of knowledge and future directions

Ahmetov, I. I., & Fedotovskaya, O. N. (2012) · Cellular and Molecular Exercise Physiology · doi:10.7457/cmep.v1i1.e1 · Cited by 59

SCD1 activity in muscle increases triglyceride PUFA content, exercise capacity, and PPARΔ expression in mice

Rogowski, M. P., Flowers, M. T., Stamatikos, A., Ntambi, J. M., & Paton, C. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035865 · Cited by 55

PPARβ/δ and lipid metabolism in the heart

Palomer, X., Barroso, E., Zarei, M., Botteri, G., & Vázquez‐Carrera, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.019 · Cited by 58

Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration

Qiu, F., Greg, M. H., Chen, Q., Zhou, K., Du, Y., Wang, X., & Ma, J. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22091 · Cited by 54

Differential actions of PPAR-α and PPAR-β/δ on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice

Rachid, T. L., Silva-Veiga, F. M., Graus‐Nunes, F., Bringhenti, I., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191365 · Cited by 56

Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?

Tufano, M., & Pinna, G. (2020) · Molecules · doi:10.3390/molecules25051062 · Cited by 57

Regulatory functions of PPARβ in metabolism: implications for the treatment of metabolic syndrome

Grimaldi, P. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.006 · Cited by 56

Pioglitazone Acutely Reduces Insulin Secretion and Causes Metabolic Deceleration of the Pancreatic β-Cell at Submaximal Glucose Concentrations

Lamontagne, J., Pépin, É., Peyot, M., Joly, E. C., Ruderman, N. B., Poitout, V., Madiraju, S. R. M., Nolan, C. J., & Prentki, M. (2009) · Endocrinology · doi:10.1210/en.2008-1557 · Cited by 54

9‐cis‐Retinoic acid enhances fatty acid‐induced expression of the liver fatty acid‐binding protein gene

Poirier, H., Braissant, O., Niot, I., Wahli, W., & Besnard, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00830-2 · Cited by 55

Peroxisome Proliferator Activated Receptor

(2006) · Springer eBooks · doi:10.1007/3-540-29719-0_1236

Printed in U.S.A. Copyright © 1998 by The Endocrine Society Differential Expression of Peroxisome Proliferator- Activated Receptor-�,-�, and- � during Rat

Development, E., Braissant, O., & Wahli, W. (2013)

Differential Expression of Peroxisome Proliferator-Activated Receptor- , - , and - during Rat Embryonic Development

Braissant, O., & Wahli, W. (1998) · Endocrinology · doi:10.1210/endo.139.6.6049 · Cited by 457

Prostaglandin and PPAR control of immune cell function

Rotondo, D., & Davidson, J. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01361.x · Cited by 20

The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation

Schoonjans, K., Staels, B., & Auwerx, J. H. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00066-5 · Cited by 1,045